APA (7th ed.) Citation

Bantounou, M. A., Sardellis, P., Thuemmler, R., Black Boada, D., Kaczmarek, J., Mahmood, R., . . . Philip, S. (2024). Effect of the dual sodium‐glucose co‐transporter‐1 and ‐2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Diabetes, Obesity & Metabolism, 26(2), 710. https://doi.org/10.1111/dom.15364

Chicago Style (17th ed.) Citation

Bantounou, Maria Anna, Panagiotis Sardellis, Rosa Thuemmler, Daniel Black Boada, Justyna Kaczmarek, Ribeya Mahmood, Josip Plascevic, and Sam Philip. "Effect of the Dual Sodium‐glucose Co‐transporter‐1 and ‐2 Inhibitor Sotagliflozin on Renal Outcomes in Type 1 Diabetes and Type 2 Diabetes: A Systematic Review and Meta‐analysis of Randomized Controlled Trials." Diabetes, Obesity & Metabolism 26, no. 2 (2024): 710. https://doi.org/10.1111/dom.15364.

MLA (9th ed.) Citation

Bantounou, Maria Anna, et al. "Effect of the Dual Sodium‐glucose Co‐transporter‐1 and ‐2 Inhibitor Sotagliflozin on Renal Outcomes in Type 1 Diabetes and Type 2 Diabetes: A Systematic Review and Meta‐analysis of Randomized Controlled Trials." Diabetes, Obesity & Metabolism, vol. 26, no. 2, 2024, p. 710, https://doi.org/10.1111/dom.15364.